OBJECTIVE: The aim of this study was to assess, by longitudinal follow-up, the in¯uence of aerobic training on the in vivo lipolytic activity of adipose tissue in obese male subjects. SUBJECTS: Eleven obese non-diabetic males, aged 41.5AE AE5.7 7 (range 27 ± 49 y) with body mass index (BMI) 36.5AE AE4.5 kga am 2 (range 29.4 ± 47.1 kga am 2 ) participated in the study. DESIGN: Subjects took part in a 12-week aerobic training program. Before and after training, microdialysis of abdominal subcutaneous adipose tissue (SCAT) was carried out, using perfusion with graded doses of the b badrenergic agonist isoprenaline and a single dose of the phosphodiesterase inhibitor theophylline. In addition, the response of plasma glycerol and free fatty acids (FFAs) to intravenous infusion of graded doses of isoprenaline was tested. RESULTS: The training did not induce signi®cant weight loss and promoted an increase in maximum aerobic capacity (P`0.05). The increase of extracellular glycerol in SCAT in response to isoprenaline perfusion was enhanced after the training (P`0.05), while no change in the response of interstitial glycerol to theophylline action was observed. The training did not elicit a change in the isoprenaline-induced changes of blood¯ow in adipose tissue. The increases of plasma FFAs and glycerol in response to intravenous isoprenaline infusion, were signi®cantly enhanced after training. CONCLUSION: The present study shows that aerobic training induced an increase in the response of plasma and subcutaneous adipose tissue concentration of glycerol to b-adrenergic stimulation. The effect of an agent acting at the post-receptor level (theophylline) in SCAT was not modi®ed by training.
Introduction
Regular physical activity has been accepted as an integral part of the treatment for obesity. In contrast to a hypocaloric diet, exercise training induces a modest reduction of fat mass (FM, depending on training volume) without a concomitant loss of fat free mass (FFM). 1 The hydrolysis of triglyceride stores (lipolysis) which releases free fatty acids (FFAs) and glycerol for adipose tissue, is a key step in the metabolic process leading to the decrease of FM. Lipolysis in humans is mainly stimulated through the b-adrenergic action of catecholamines and inhibited through the a2-adrenergic pathway and by insulin. 2 In healthy non-obese subjects, several studies have shown that exercise training induces an increase in catecholamine-stimulated lipolysis in isolated adipocytes; either in cross sectional 3 ± 5 or longitudinal 6 designs. An increased sensitivity of adipose tissue to the lipolytic action of catecholamines can facilitate lipid mobilization from fat stores. The results of in vivo studies investigating whole-body basal lipolysis at rest were unequivocal: higher 7 as well as lower 8 FFA release from adipose tissue, was found in trained subjects. Finally, in situ examination of adrenaline-stimulated lipolysis in subcutaneous adipose tissue (SCAT) using the microdialysis technique, 9 did not ®nd any difference between trained and untrained subjects. A recent study examined the effect of training combined with diet on in vitro lipolysis in obese subjects and found that the dietary-induced decline of lipolysis was blunted by training. 10 To our knowledge, no study has examined whether modi®cations in the regulation of lipolysis in adipose tissue occur in obese subjects submitted to aerobic training without a concomitant nutritional intervention. Alterations of catecholamine-stimulated lipolysis have been reported in obese subjects 11, 12 and, therefore, it is of particular interest whether the disturbed lipolytic sensitivity can be in¯uenced by training.
The present study was undertaken to investigate the effect of 12 weeks aerobic training on adipose tissue lipolysis in obese male subjects. The microdialysis method was used to assess the interstitial glycerol concentration, as an index of lipolysis, before and after the training. The microdialysis probes were perfused with agents acting at the receptor (isoprenaline, b-adrenergic agonist) and post-receptor (theophylline) level. In addition, in an attempt to evaluate the training effect quantitatively on the whole body response to isoprenaline stimulation, in vivo responses of plasma glycerol and FFAs to isoprenaline infusion were examined.
Methods

Subjects
Eleven obese non-diabetic males, aged 41.5 AE 5.7 y (range 27 ± 49 y) were recruited for the study. The subjects' characteristics are presented in Table 1 . One patient was treated for mild hypertension with calcium channel antagonists, one patient was treated with a small dose of thyroxine (75 mgad) for hypothyroidism. All the subjects were sedentary prior to the study. Their weight had been stable for six months prior to the study. Their nutritional status had not changed during that period and they were instructed not to change their nutritional habits during the course of the study. The stable nutritional pattern was veri®ed using a four-day dietary record, obtained at the beginning, at the sixth week and at the end of the study period. The experiment was approved by the Ethics Committee of the 3rd Medical Faculty of Charles University, Prague. All subjects gave their informed consent to participate in the study.
Subjects took part in the 12-week aerobic training program described below. Before and after the training program the following measurements and tests were carried out: body composition measurements, assessment of maximal oxygen uptake ( VO 2 max), laboratory evaluation of blood lipids, evaluation of blood glucose and insulin response to oral glucose load, microdialysis of abdominal SCAT and a test with graded-dose intravenous isoprenaline infusion. The tests were performed at least 48 h after the last exercise session, in order to exclude its effects on the results.
Maximum aerobic capacity VO 2 max was assessed using a graded test conducted on an electromagnetically braked bicycle ergometer (Ergometrics 800s Ergoline, Jaeger, Germany). The initial work load was 50 watts and it was increased by 0.2 Wattsakg of FFM every minute until exhaustion. VO 2 was measured using a Vmax apparatus (Sensor Medics, Yorba Linda, CA) during the test, and the highest VO 2 value was considered as VO 2 max.
Exercise training protocol
The training program consisted of exercise on a bicycle ergometer for four days each week; duration of the session was 30 ± 45 min, following individual prescription. The subjects cycled at a target heart rate calculated from the Karvonen equation. 13 The heart rate corresponded to 50% of the heart rate reserve (maximal heart rate minus resting heart rate) during the ®rst two weeks and progressed to 55 ± 70% of the heart rate reserve during the subsequent weeks.
Anthropometric assessment
Before and after the training, body composition was determined by hydrostatic weighing using the method of Siri.
14 Lung volume measurement was carried out using plethysmography (Vmax Apparatus, Sensor Medics, Yorba Linda, CA).
Oral glucose tolerance test
Oral glucose tolerance test (OGTT) was performed by oral administration of 100 g glucose. Blood glucose and plasma immunoreactive insulin were determined in the basal state, and one and two hours after glucose intake.
In vivo isoprenaline test
The subjects were examined in the supine position after an overnight fast. Two intravenous catheters were inserted into the antecubital vein, one in each arm. One catheter was used for isoprenaline infusion, the other one for blood sampling. After a 20 min rest period, the ®rst blood sample was drawn for determination of basal values. Thereafter, the infusion of isoprenaline diluted in a saline solution was started. The isoprenaline solution was protected from light degradation by wrapping aluminium foil around the syringe and the infusion line connected to the subject. Three sequential doses of isoprenaline were used: 0.02, 0.04 and 0.06 mgaminakg of FFM. Each dose was infused for 10 min and blood sampling was performed during the last minute of each 10 min interval. Heart rate and blood pressure were monitored continuously. Infusion was interrupted when the subject's heart rate exceeded 130 bpm, which occurred in one subject at the highest rate of infusion.
Dialysis experiment
For dialysis experiments the subjects were investigated in the supine position after an overnight fast. Two microdialysis probes (Carnegie Medecin, Stockholm, Sweden) of 20 Â 0.5 mm and 20 000-MW cutoff were inserted percutaneously after epidermal anaesthesia (200 ml of lidocaine 1%, Roger-Bellon, Neuilly-s-Seine, France) into the abdominal SCAT at a distance of 100 mm immediately to the right and the left of the umbilicus. The probes were connected to a microinjection pump (Harvard Apparatus, SARL, Les Ulis, France) and perfused at a¯ow rate of 0.5 mlamin with sterile Ringer's solution (154 mmolal sodium, 4 mmolal potassium, 2.5 mmolal calcium, 160 mmolal chloride) supplemented with ethanol (1.7 gal). Ethanol
In situ lipolysis in training obese V Stich et al was added to the perfusate in order to estimate changes in the adipose blood¯ow, as previously described. 15 No outgoing dialysate was collected during the ®rst 30 min after implantation. Then, the in vivo recovery rate was evaluated for each probe, by measuring dialysate glycerol concentrations at various perfusion rates. This calibration procedure was previously described for the estimation of the extracellular amino acid concentration in the brain, 16 recently applied to interstitial glycerol concentration in muscle and adipose tissue 17 and previously described by our group. 15 Brie¯y, the probes were perfused at four successive rates (0.5 mlamin, 1.5 mlamin, 2.5 mlamin and 3.5 mlamin), separated by appropriate wash out periods, and the glycerol concentrations determined in the dialysate for each perfusion rate. Dialysate concentrations were plotted (after log-transformation) against the perfusion rates. Linear regression analysis was used to calculate the glycerol concentration at zero¯ow', corresponding to the interstitial glycerol concentration. The ratio between dialysate glycerol concentration at 2.5 mlamin and calculated interstitial glycerol concentration, represented the in vivo recovery rate of the probe. Then, the perfusion¯ow rate was maintained at 2.5 mlamin during the whole experimental period.
Four 10 min fractions of each probe were collected to evaluate basal levels and then isoprenaline was added to the perfusate with two rising concentrations (0.1 mmolal and 1 mmolal). Each dose was applied for 40 min (concentration-periods) and four successive fractions were collected during the different concentration-periods. Theophylline was perfused in the second probe at a constant concentration (10 mmolal) and successive 10 min fractions were collected for 80 min.
Glycerol (lipolysis index) analysis was performed in each collected fraction. The changes in the blood ow were assessed by measuring, as previously described, 18, 19 the ethanol out¯owain¯ow ratio during the basal period and at each dose period.
Biochemical determination
Glycerol in dialysate (10 ml) and in plasma (20 ml) was analysed with an ultrasensitive radiometric method, 20 the intra-assay and interassay variabilities were 5.0% and 9.2%, respectively. Ethanol in dialysate and perfusate (5 ml) was determined with an enzymatic method, 21 the intra-assay and interassay variabilties were 3.0% and 4.5%, respectively. Plasma glucose and FFAs were determined with a glucose-oxidase technique (Biotrol kit, Merck-Clevenor, Nogent-sMarne, France) and an enzymatic procedure (Wako kit, Unipath, Dardilly, France), respectively. Plasma insulin concentrations were measured by radioimmunoassay (RIA) using kits from Sano® Diagnostics Pasteur (Marnes la Coquette, France). Plasma triglycerides and cholesterol were assayed with commercial reagents.
Reagents
Isoprenaline hydrochloride (Isuprel 1 ) was obtained from Winthrop (Clichy, France) and theophylline (theophylline Bruneau) from Delalande (Que Âtigny, France).
Statistical analysis
All the values are meansAE s.e.m. Flow rate calibration data were analyzed by linear regression tested for goodness of ®t. The signi®cance of differences was assessed using Student's paired t test and analysis of variance (ANOVA) with Bonferroni's and StudentNewman-Keuls' tests for post hoc analysis. Signi®-cance values are quoted in the text and ®gures. P`0.05 was considered statistically signi®cant. All calculations were performed using software statistical packages (Superanova and Statview, Abacus Concepts Inc., Berkeley, CA).
Results
Physical characteristics
The training program resulted in an increase of total VO 2 max by 6.3%, but the increase was not signi®cant when VO 2 max was related to FFM (Table 1) . Maximum work output on the bicycle ergometer increased by 8.9%. The training did not produce any signi®cant In situ lipolysis in training obese V Stich et al change in body weight, the percentage of FM decreased signi®cantly, but there was no change in FFM. There was a signi®cant decrease in the waist circumference.
Blood results
FFA concentrations were slightly higher after, than before, training, the difference not being signi®cant and no signi®cant change was observed in plasma glycerol concentrations ( 
OGTT
The basal plasma concentrations of glucose and insulin, were not changed by training (5.01 AE 0.32 vs 5.54 AE 0.51 mmolal and 21.2AE 3.1 vs 24.3 AE 2.7 mUaml, respectively). OGTT was performed before and after training. The calculated area-under-thecurve (AUC) for plasma glucose, was signi®cantly lower after, than before, training (18.4AE 2.5 vs 23.7 AE 2.7 mmola120 min; P`0.003). The calculated AUC for plasma insulin was lower after training, however the decrease was not signi®cant, due to large interindividual variations (174.3AE 31.9 vs 238.9 AE 49.8 mUamla120 min).
In vivo isoprenaline test
The isoprenaline-induced increase in plasma glycerol and FFA concentrations was signi®cantly more pronounced after training than before (Table 2) . Isoprenaline induced a weak increase in plasma glucose concentration after training but not before, the corresponding calculated AUCs for isoprenaline-induced changes in plasma glucose, were 1.8 AE 0.3 and 70.4 AE 0.3 mmola30 min (P`0.03). The isoprenaline-induced increase in plasma insulin concentration tended to be greater after training, but the difference was not signi®cant, due to large interindividual variations (AUCs were 78.2 AE 15.5 vs 57.0AE 6.6 mUamla30 min; P`0.17). Training did not modify resting heart rate (60.8 AE 1.8 vs 63.5 AE 2.3 bpm; P 0.14). However, the isoprenaline-induced increase in heart rate was higher after training; the increases were 24.3AE 1.8, 45.4AE 3.2, 58.8AE 2.5 vs 17.9AE 3.5, 38.3AE 3.6, 47.5 AE 4.4 bpm, for 0.02, 0.04 and 0.06 mgaminakg FFM of isoprenaline infusion, respectively (ANOVA with repeated measures, P`0.01).
Effect of training on lipolytic activity in subcutaneous adipose tissue
In order to evaluate the modi®cations of lipolysis and sensitivity of the b-adrenergic pathway, the microdialysis examination of abdominal SCAT was carried out. No training-induced difference in the baseline extracellular glycerol levels was detected (320.0AE 20.1 mmolal after vs 295.6AE 6.8 mmolal before training).
Both before and after training, locally administered isoprenaline induced a concentration-dependent increase in extracellular glycerol concentrations ( Figure 1A ). The increase above the baseline level (fractions, 10 ± 40 min) was already signi®cant (P0 .05) at the concentration of 0.1 mmolal, before as well as after training. At a concentration of 1.0 mmolal, the glycerol levels rose signi®cantly (P`0.05) above that of the previous concentration in both periods. The two curves representing the concentration-dependent increase of glycerol before vs after training were different (ANOVA with repeated measures, P`0.05). The blood¯ow in SCAT was evaluated using the ethanol in¯owaout¯ow ratio. No change due to training was found in basal values. The in¯owaout¯ow ratio decreased (P`0.05) during isoprenaline perfusion in a concentrationdependent manner in both periods, indicating the vasodilating effect of isoprenaline ( Figure 1B) . The curves representing the concentration-dependent response of the in¯owaout¯ow ratio to isoprenaline before and after training were not different (ANOVA with repeated measures), which indicated no training-induced change in the vasodilating effect of isoprenaline in adipose tissue. Values are mean AE s.e.m. After basal measurement, isoprenaline was infused at rates of 0.02, 0.04 and 0.06 mgaminakg fat free mass (FFM), for 10 min at each rate. Areas-under-the-curve (AUCs; mmolala30 min) were calculated using the absolute increments of plasma FFAs and glycerol concentrations.
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In order to evaluate the putative role of post-badrenergic receptor mechanisms in the increase of isoprenaline-induced extracellular glycerol concentration observed after training, theophylline was perfused in the second probe at a constant concentration (10 mmolal). As for the ®rst probe, no traininginduced differences in the extracellular glycerol concentrations in the basal fractions were detected (271.6AE 16.5 mmolal after vs 309.6AE 14.2 mmolal before training). Theophylline induced a signi®cant increase of extracellular glycerol concentrations above the basal values (fractions 10 ± 40 min) in both periods ( Figure 2A ) (P`0.05). The two curves depicting the overall responses to theophylline before and after training were not statistically different (ANOVA with repeated measures). The basal blood ow measured in this second probe was not different before and after training ( Figure 2B ). In both periods theophylline decreased the ethanol out¯owain¯ow ratio compared to basal values (P`0.05), indicating Figure 1 A. Effect of the non-selective b-adrenoceptor agonist isoprenaline on the interstitial glycerol levels in subcutaneous adipose tissue (SCAT) from obese subjects (n 11) before and after 12 weeks of aerobic training. After 40 min (basal period), increasing concentrations of isoprenaline were added to the perfusate, indicated by arrows. Values are means AE s.e.m. Statistical comparison of the curves was performed using ANOVA for repeated measures, with training period (after vs before) and time as factors in this analysis. The two curves were different (F 3.56; P`0.05). B. Effect of the non-selective b-adrenoceptor agonist isoprenaline on the ethanol ratio (ethanol dialysate levelaethanol perfusate level) in SCAT from obese subjects (n 11) before and after 12 weeks of aerobic training. Values are means AE s.e.m. Statistical comparison of the curves was performed using ANOVA for repeated measures, with training period (after vs before) and time as factors in the analysis. The two curves were not different.
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Discussion
The main ®nding of this study is that, in obese male subjects, aerobic training (corresponding to the training volume used in routine clinical practice for the obese), promotes an increase in b-adrenergic-stimulated lipolytic activity in situ in SCAT. In this study, the training produced a minor (although signi®cant) change in the physical ®tness of subjects (evaluated by maximum aerobic capacity). It did not produce a signi®cant change in body weight while there was a slight decrease in the FM and no change in FFM. The modest effects of this kind of training are in agreement with other reports on the effects of moderate aerobic training on obese subjects. 22 ± 24 In spite of the mild effects on physical ®tness and body composition, the training resulted in a decrease of plasma total cholesterol and in a signi®cant improvement of glucose tolerance estimated with OGTT.
The basal rate of lipolysis did not appear to be changed by training: as judged by the lack of signi®cant change in basal plasma concentrations of glycerol and FFAs. In response to isoprenaline infusion, the plasma concentrations of both metabolites increased in a dose-dependent manner and the increase was more pronounced in the post-vs pretraining state (Table 2) . This ®nding suggests an enhancement of the lipolytic response to catecholamines: the plasma insulin response to isoprenaline infusion, which could in¯uence the response of glycerol and FFAs, was not modi®ed by training. A similar training-induced enhancement of the response of plasma FFAs and glycerol to adrenaline infusion, has been observed in non-obese subjects. 25 Obese subjects have been shown to have a lower isoprenaline-induced FFA and glycerol release. 26 From the present study, it appears that this impairment could be changed by training. However, the training-induced increase of plasma glycerol and FFA responses to isoprenaline may re¯ect more than the changes of in vivo adipose tissue lipolytic rates, because the metabolite plasma concentrations are determined by both lipolysis and utilization rates. In addition to the isoprenaline-infusion-induced effect on lipid metabolites, we found a training-induced increase of the response of heart rate to isoprenaline stimulation, suggesting an increased sensitivity of cardiac chronotropic function to b-adrenergic action. This corresponds to previous ®ndings in obese subjects during training. 27 In the microdialysis examination, the baseline values of interstitial glycerol in adipose tissue (calculated from the glycerol concentrations in dialysate) were not changed after training ( Figure 1A) . The values of interstitial glycerol found in the obese subjects of the present study are in agreement with those observed previously by others 28 and ourselves. 29 In both the pre-and post-training states, isoprenaline induced an increase in interstitial glycerol concentration in SCAT. The pre-training isoprenaline-induced increase in interstitial glycerol concentration was close in magnitude to that found in our previous microdialysis study of obese subjects. 29 The response of interstitial glycerol to isoprenaline stimulation was higher after 12 weeks of training. A similar enhancement of isoprenaline-induced interstitial glycerol concentration in situ was found during the very-lowcalorie diet (VLCD) in our previous study of obese subjects.
29 Figure 2 A. Effect of the phosphodiesterase inhibitor theophylline on the interstitial glycerol concentrations in subcutaneous adipose tissue (SCAT) from obese subjects (n 11) before and after 12 weeks of aerobic training. After 40 min (basal period), theophylline was added to the perfusate, indicated by arrows. Value are means AE s.e.m. Statistical comparison of the curves was performed using ANOVA for repeated measures, with training period (after vs before) and time as factors in the analysis. The two curves were not different. B. Effect of the phosphodiesterase inhibitor theophylline on the ethanol ratio (ethanol dialysate levelaethanol perfusate level) in SCAT from obese subjects (n 11) before and after 12 weeks of aerobic training. Values are means AE s.e.m. Statistical comparison of the curves was performed using ANOVA for repeated measures with training period (after vs before) and time as factors in the analysis. The two curves were not different.
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The isoprenaline perfusion of the dialysis probe induced a concentration-dependent increase of blood ow, as evaluated by the ethanol wash-out technique. The relative change of the adipose tissue blood ow in response to isoprenaline was not different before and after training. This suggests that the vasodilator effect of isoprenaline was not modi®ed by training and thus, the increase of interstitial glycerol in response to isoprenaline was in¯uenced in the same manner before and after training. Consequently, the higher isoprenaline-induced increase in interstitial glycerol concentration after training, suggests that training induced an enhancement of b-adrenergically mediated lipolysis in fat cells.
The results of the microdialysis measurement in this study are in agreement with one of the rare longitudinal studies in which the training-induced increase of adrenaline-stimulated lipolysis of adipocytes in vitro was observed after 20 weeks training in non-obese subjects. 6 The only microdialysis study which examined changes in lipolysis in SCAT related to training was that of Stallknecht et al. 9 They found, in a cross-sectional design, no differences in adrenaline-stimulated lipolysis between trained and untrained subjects. The results of our study are hardly comparable with those of Stallknecht et al, 9 because of the different design: 1) the latter study compared two groups of individuals with highly different training status and body fatness and 2) a different way was used for catecholamine administration (intravenous).
In order to try to further elucidate the level of the lipolytic cascade at which the training-induced changes in b-adrenergic lipolytic action occurs, the response to a post-receptor agent (a phosphodiesterase inhibitor, theophylline) perfused in the probes was evaluated. A signi®cant increase in the response of interstitial glycerol concentration to this agent was observed before as well as after the training and a signi®cant vasodilating effect of the substance was found. The theophylline-induced responses did not differ in the pre-vs post-training state. This suggests that the training-induced enhancement of b-adrenergic lipolytic action is produced at a level proximal to cyclic AMP formation. However, an effect of training to blunt the normal effect of isoprenaline to stimulate phosphodiesterase cannot be ruled out.
It has been shown that the in situ lipolytic response of adipose tissue to an acute exercise bout is speci®c with respect to fat deposit location and gender. 30 The gender-speci®c and the location-speci®c effects of training were also found in in vitro studies. 4, 5, 31 Therefore, it is important to note that the traininginduced modi®cations in the present study are speci®c for male subjects and for subcutaneous abdominal deposits.
Conclusion
The present study reports that, in obese males, 12 weeks of aerobic training promotes an increase in the response of plasma and subcutaneous adipose tissue concentration of glycerol during b-adrenergic stimulation. This suggests an increase in b-adrenergically mediated lipolysis. The effect of an agent acting at the post-receptor level (theophylline) in SCAT was not modi®ed by training. The results suggest that the lowered b-adrenergic responsiveness reported in obese subjects may be improved by exercise training.
